-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics Sees FY2026 Sales $46.000M-$50.000M vs $49.888M Est

Benzinga·03/04/2026 21:03:04
Listen to the news
Aquestive Therapeutics (NASDAQ:AQST) sees FY2026 sales of $46.000 million-$50.000 million vs $49.888 million analyst estimate.